Quantcast

Latest Prostate cancer Stories

2014-05-28 04:24:16

Canadians need to protect themselves more from dangerous ultraviolet rays TORONTO, May 28, 2014 /CNW/ - Melanoma skin cancer is one of the fastest rising of all cancers in Canada; Canadians need to do more to protect themselves from damaging ultraviolet (UV) radiation, according to a special report on skin cancer. Canadian Cancer Statistics 2014 was released today by the Canadian Cancer Society in partnership with the Public Health Agency of Canada and Statistics Canada. Skin...

2014-05-27 23:03:55

Humility of Mary Health Partners will provide free PSA blood draws to check 100 men for prostate cancer during the Fuel the Fight car and motorcycle show June 1 at Boardman High School. Youngstown, Ohio (PRWEB) May 27, 2014 Humility of Mary Health Partners will provide 100 free PSA blood draws to check for prostate cancer during the Fuel the Fight car and motorcycle show June 1 in Boardman. Fuel the Fight, sponsored by the HMHP Foundation and Sweeney Chevrolet, Buick, GMC, benefits Man Up...

2014-05-27 16:25:20

-Files patents on markers- TEL AVIV, Israel, May 27, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd. (OTC: BLGTY, TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that Micromedic Technologies (TASE: MCTC), BioLight's cancer diagnostic cluster company, has identified several new genetic markers with high potential to predict necrosis of the jawbone in multiple...

2014-05-27 12:32:49

BETHESDA, Md., May 27, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio) announced today that the Company will host a conference call and webcast with CEO Linda Powers today, May 27, 2014, at 4:30 p.m. Eastern time to review the early results of the Phase I/II DCVax®-Direct Trial announced this morning and answer questions. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO Participants must register in order to participate in the conference call. There are...

2014-05-27 12:30:29

CHARLOTTE, N.C., May 27, 2014 /PRNewswire/ -- Medical device manufacturer SonaCare Medical reports continuing strong European sales as well as a positive outlook in light of official guideline changes for prostate cancer therapy. The company has further invested in the European market by adding its newest generation high intensity focused ultrasound ("HIFU") equipment to the HIFU center of excellence at University College of London. Following a strong 2013 with six thermal ablation...

2014-05-27 08:29:27

Initial Responses Seen Before Patients Have Completed Treatments; BETHESDA, Md., May 27, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today provided a summary of initial data to date in its ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors. The Company reported that over 50% of the patients who have completed at least half of...

2014-05-27 08:27:52

SYDNEY, May 27, 2014 /PRNewswire/ -- Novogen Limited (NASDAQ: NVGN, ASX:NRT), an oncology drug development company, today announced that it has achieved a key milestone with its super-benzopyran (SBP) drug program, having identified a number of SBP compounds with potent anti-cancer activity against human prostate cancer cells in vitro. As a result, Novogen has extended its preclinical SBP program to include prostate cancer as well as ovarian and brain cancers....

2014-05-27 08:27:46

-- High calibre German consulting company appointed to assist CE Mark registration process SYDNEY, May 27, 2014 /PRNewswire/ -- Australian biotechnology company Minomic International Limited will register its MiStat(TM) ELISA prostate cancer test for CE Mark approval in the latter part of 2014. Achieving CE approval will be a key commercial milestone for the company, allowing it to sell and market its early detection diagnostic technology in the 33 member countries within the...

2014-05-27 04:21:40

SINGAPORE and LAUSANNE, Switzerland, May 27, 2014 /PRNewswire/ -- Orient EuroPharma Co., Ltd. (Orient EuroPharma) a specialty pharmaceutical company focused in marketing and commercialization with subsidiaries across Hong Kong, Malaysia, Singapore, Philippines with a strong sales network of 360 dedicated and experienced sales representatives and Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet...

2014-05-23 12:24:55

LA JOLLA, Calif., May 23, 2014 /PRNewswire-USNewswire/ -- The California Institute for Biomedical Research (Calibr) has received a Translation Award from the Wellcome Trust to develop a novel semi-synthetic antibody-based immunotherapy to treat hormone-refractory prostate cancer. The novel therapeutic agent engages the patient's own immune system to selectively destroy prostate tumor cells. This approach offers a potentially more efficacious and safer alternative to traditional...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related